BioLineRx Ltd Strategic Asset Allocation Index
BioLineRx Ltd strategic asset allocation index. BioLineRx Ltd (BLRX) has a Strategic Asset Allocation Index of 10.6% as of June 2023. Strategic assets (PP&E of $2.23 Million plus long-term investments of $-) total $2.23 Million, measured against net assets of $21.05 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See BioLineRx Ltd (BLRX) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of BioLineRx Ltd (2010–2021)
Strategic asset allocation index of BioLineRx Ltd from 2010 to 2021. This chart shows how BioLineRx Ltd's Strategic Asset Allocation Index has evolved across 12 annual periods from 2010 to 2021. As of June 2023, the index stands at 10.6%, representing strategic assets of $2.23 Million against net assets of $21.05 Million USD. Check BioLineRx Ltd (BLRX) tangible equity ratio to evaluate the tangible quality of the company's equity base.
BioLineRx Ltd Strategic Asset Allocation Index by Year (2010–2021)
BioLineRx Ltd strategic asset allocation index by year from 2010 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for BioLineRx Ltd from 2010 to 2021, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see BLRX stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 3.4% | $2.28 Million | $2.28 Million | $- | $68.09 Million | ▼ -8.9 pp |
| 2020 | 12.2% | $2.70 Million | $2.70 Million | $- | $22.03 Million | ▲ +1.9 pp |
| 2019 | 10.4% | $3.47 Million | $3.47 Million | $- | $33.38 Million | ▲ +5.0 pp |
| 2018 | 5.4% | $2.23 Million | $2.23 Million | $0.00 | $41.32 Million | ▼ -1.2 pp |
| 2017 | 6.6% | $3.50 Million | $2.50 Million | $1.00 Million | $52.88 Million | ▼ -0.8 pp |
| 2016 | 7.4% | $2.60 Million | $2.60 Million | $- | $35.03 Million | ▲ +1.3 pp |
| 2015 | 6.1% | $2.91 Million | $2.91 Million | $- | $47.61 Million | ▲ +3.8 pp |
| 2014 | 2.3% | $718.00K | $718.00K | $- | $31.77 Million | ▼ -3.8 pp |
| 2013 | 6.1% | $710.00K | $710.00K | $- | $11.68 Million | ▲ +0.4 pp |
| 2012 | 5.7% | $852.00K | $852.00K | $- | $14.97 Million | ▲ +0.8 pp |
| 2011 | 4.9% | $1.11 Million | $1.11 Million | $- | $22.53 Million | ▲ +1.5 pp |
| 2010 | 3.4% | $1.27 Million | $1.27 Million | $- | $37.26 Million | — |